Dedalus welcomes the opportunity to provide input to the European Commissions Digital Omnibus proposal. As a European leader in Software as a Medical Device (SaMD) and AIenabled medical devices (MDAI), serving large hospital networks across the Union, Dedalus strongly supports the objective of creating a predictable, innovationfriendly, and clinically safe digital regulatory environment.
Dedalus Group
Company · Italy · EU Transparency Register 810154494287-18
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1210 companies & groups on this site, they rank #129 by legislative files engaged, a count of participation, not a measure of influence.
Declares membership of
- Trade organization COCIR (www.cocir.org),
- HIMSS (https://www.himss.org/),
- IHE-Europe (https://www.ihe-europe.net/),
- openEHR (https://openehr.org/)
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Companies & groups
- Registered as
- Dedalus S.p.A.
- Head office
- Milano, Italy
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Dedalus in PolicySpeak: request access →
Work at Dedalus Group? so we know who speaks for it.
Their record over time
Dedalus Group filed 12 positions between 15 Apr 2025 and 24 Sept 2026, across 10 of the 665 legislative files tracked here, attaching a full position paper 8 times.
What they argued
Dedalus, a European medical software manufacturer, welcomes the Digital Omnibus initiative and urges the EU to simplify and harmonize digital regulations. The current landscape (GDPR, MDR, IVDR, NIS2, CRA, AI Act, etc.) is complex, with overlapping and sometimes conflicting requirements that increase compliance risks and administrative burden.
MDR/IVDR Targeted Revision (COM(2025) 1023): Dedalus, a European healthcare software group (7,000+ employees, standalone software medical devices used by hospitals across the EU), welcomes the Commission proposal as a strong basis for restoring proportionality, predictability and international competitiveness while maintaining patient safety.
Dedalus is a well-established European-based medical software manufacturer regulated under MDR and IVDR. Our portfolio spans primary care, hospital systems, diagnostics, emergency care, and population health management.
Health IT applications have mission-critical components that directly support clinical decision-making, patient identification, medication management, diagnostics, care coordination, and continuity of operations.
Dedalus welcomes the opportunity to provide input to the Cybersecurity Act 2 and NIS2 Simplification Measures proposals. As a European leader in Software as a Medical Device (SaMD) and AIenabled medical devices (MDAI), serving large hospital networks across the Union, Dedalus strongly supports the objective of creating a predictable, innovationfriendly, and clinically safe digital regulatory environment.
1. Quantum-safe protection of sensitive health data. The Act should explicitly support the transition to post-quantum cryptography (PQC) for electronic health records, communications, digital signatures, and authentication systems, in coordination with ENISA, ETSI, EuroQCI and national cybersecurity authorities. 2. Quantum-ready interoperability and standards.
In the attached working paper Dedalus Group responds to the European Commissions consultation on the Digital Decade Policy Programme (DDPP) 2030, offering our perspective as a leading innovator in digital healthcare.
Dedalus S.p.A., as a group developing and distributing medical software within the European Union, would like to express our sincere appreciation for the European Commission's efforts in advancing cybersecurity through the Cyber Resilience Act (CRA). We welcome the orientation, clarity, and strategic foresight demonstrated by the CRA.
Dedalus outlines the following core industrial priorities for the European implementation framework for Secondary Use of data: Valuing the Role of Qualified "Service Providers" (Article 9): The draft law allows national hubs (NCPs/HDABs) to hire external technology partners. Private tech companies are ready to cooperate in building and running such network.
Dedalus Group welcomes the publication of the draft implementing regulation on the European Health Data Space (EHDS) Board and appreciates the effort to establish a governance framework that promotes coordination and transparency. In this context, we would like to offer some recommendations aimed at strengthening inclusiveness, clarity, and moving to effective implementations.
The European Interoperability Framework should continue to play a central role in enabling the effective functioning of cross-border digital public services. Its core principlesmultilayer interoperability, reuse, openness and interoperability by designremain valid and should be further strengthened.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Dedalus Group next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 215.
Is this your organization?
Everything on this page comes from Dedalus Group’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.